Reviewed,
UniProtKB/Swiss-Prot Q00975 (CAC1B_HUMAN)
Last modified
January 19, 2010.
Version 97.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Voltage-dependent N-type calcium channel subunit alpha-1B Alternative name(s): Voltage-gated calcium channel subunit alpha Cav2.2 Calcium channel, L type, alpha-1 polypeptide isoform 5 Brain calcium channel III Short name=BIII | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 2339 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1B gives rise to N-type calcium currents. N-type calcium channels belong to the 'high-voltage activated' (HVA) group and are blocked by omega-conotoxin-GVIA (omega-CTx-GVIA) and by omega-agatoxin-IIIA (omega-Aga-IIIA). They are however insensitive to dihydropyridines (DHP), and omega-agatoxin-IVA (omega-Aga-IVA). Calcium channels containing alpha-1B subunit may play a role in directed migration of immature neurons. |
| Subunit structure | Multisubunit complex consisting of alpha-1, alpha-2, beta and delta subunits in a 1:1:1:1 ratio. The channel activity is directed by the pore-forming and voltage-sensitive alpha-1 subunit. In many cases, this subunit is sufficient to generate voltage-sensitive calcium channel activity. The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity. Interacts with RIMS1 and RIMBP2 By similarity. |
| Subcellular location | |
| Tissue specificity | Isoform Alpha-1b-1 and isoform Alpha-1b-2 are expressed in the central nervous system, but not in skeletal muscle or aorta. |
| Domain | Each of the four internal repeats contains five hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one positively charged transmembrane segment (S4). S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position. |
| Post-translational modification | Phosphorylated in vitro by CaM-kinase II, PKA, PKC and CGPK By similarity. Ref.4 Ref.5 |
| Sequence similarities | Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family. [View classification] Contains 1 EF-hand domain. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Alpha-1B-1 (identifier: Q00975-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Alpha-1B-2 (identifier: Q00975-2) The sequence of this isoform differs from the canonical sequence as follows: 2164-2339: GSGSVNGSPL...YHHPDQDHWC → AGSAVGFPNT...APPGLPTCPP |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 2339 | 2339 | Voltage-dependent N-type calcium channel subunit alpha-1B | PRO_0000053921 | |||||
Regions | |||||||||
| Topological domain | 1 – 95 | 95 | Cytoplasmic Potential | ||||||
| Transmembrane | 96 – 114 | 19 | S1 of repeat I Potential | ||||||
| Topological domain | 115 – 132 | 18 | Extracellular Potential | ||||||
| Transmembrane | 133 – 152 | 20 | S2 of repeat I Potential | ||||||
| Topological domain | 153 – 163 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 164 – 183 | 20 | S3 of repeat I Potential | ||||||
| Topological domain | 184 – 187 | 4 | Extracellular Potential | ||||||
| Transmembrane | 188 – 206 | 19 | S4 of repeat I Potential | ||||||
| Topological domain | 207 – 225 | 19 | Cytoplasmic Potential | ||||||
| Transmembrane | 226 – 245 | 20 | S5 of repeat I Potential | ||||||
| Topological domain | 246 – 331 | 86 | Extracellular Potential | ||||||
| Transmembrane | 332 – 356 | 25 | S6 of repeat I Potential | ||||||
| Topological domain | 357 – 482 | 126 | Cytoplasmic Potential | ||||||
| Transmembrane | 483 – 501 | 19 | S1 of repeat II Potential | ||||||
| Topological domain | 502 – 516 | 15 | Extracellular Potential | ||||||
| Transmembrane | 517 – 536 | 20 | S2 of repeat II Potential | ||||||
| Topological domain | 537 – 544 | 8 | Cytoplasmic Potential | ||||||
| Transmembrane | 545 – 562 | 18 | S3 of repeat II Potential | ||||||
| Topological domain | 563 – 573 | 11 | Extracellular Potential | ||||||
| Transmembrane | 574 – 592 | 19 | S4 of repeat II Potential | ||||||
| Topological domain | 593 – 611 | 19 | Cytoplasmic Potential | ||||||
| Transmembrane | 612 – 631 | 20 | S5 of repeat II Potential | ||||||
| Topological domain | 632 – 684 | 53 | Extracellular Potential | ||||||
| Transmembrane | 685 – 709 | 25 | S6 of repeat II Potential | ||||||
| Topological domain | 710 – 1151 | 442 | Cytoplasmic Potential | ||||||
| Transmembrane | 1152 – 1169 | 18 | S1 of repeat III Potential | ||||||
| Topological domain | 1170 – 1185 | 16 | Extracellular Potential | ||||||
| Transmembrane | 1186 – 1205 | 20 | S2 of repeat III Potential | ||||||
| Topological domain | 1206 – 1217 | 12 | Cytoplasmic Potential | ||||||
| Transmembrane | 1218 – 1236 | 19 | S3 of repeat III Potential | ||||||
| Topological domain | 1237 – 1246 | 10 | Extracellular Potential | ||||||
| Transmembrane | 1247 – 1265 | 19 | S4 of repeat III Potential | ||||||
| Topological domain | 1266 – 1284 | 19 | Cytoplasmic Potential | ||||||
| Transmembrane | 1285 – 1304 | 20 | S5 of repeat III Potential | ||||||
| Topological domain | 1305 – 1391 | 87 | Extracellular Potential | ||||||
| Transmembrane | 1392 – 1416 | 25 | S6 of repeat III Potential | ||||||
| Topological domain | 1417 – 1471 | 55 | Cytoplasmic Potential | ||||||
| Transmembrane | 1472 – 1490 | 19 | S1 of repeat IV Potential | ||||||
| Topological domain | 1491 – 1505 | 15 | Extracellular Potential | ||||||
| Transmembrane | 1506 – 1525 | 20 | S2 of repeat IV Potential | ||||||
| Topological domain | 1526 – 1533 | 8 | Cytoplasmic Potential | ||||||
| Transmembrane | 1534 – 1552 | 19 | S3 of repeat IV Potential | ||||||
| Topological domain | 1553 – 1563 | 11 | Extracellular Potential | ||||||
| Transmembrane | 1564 – 1582 | 19 | S4 of repeat IV Potential | ||||||
| Topological domain | 1583 – 1601 | 19 | Cytoplasmic Potential | ||||||
| Transmembrane | 1602 – 1621 | 20 | S5 of repeat IV Potential | ||||||
| Topological domain | 1622 – 1683 | 62 | Extracellular Potential | ||||||
| Transmembrane | 1684 – 1708 | 25 | S6 of repeat IV Potential | ||||||
| Topological domain | 1709 – 2339 | 631 | Cytoplasmic Potential | ||||||
| Repeat | 82 – 359 | 278 | I | ||||||
| Repeat | 468 – 712 | 245 | II | ||||||
| Repeat | 1137 – 1419 | 283 | III | ||||||
| Repeat | 1456 – 1711 | 256 | IV | ||||||
| Domain | 1724 – 1759 | 36 | EF-hand | ||||||
| Nucleotide binding | 451 – 458 | 8 | ATP Potential | ||||||
| Calcium binding | 1737 – 1748 | 12 | By similarity | ||||||
| Region | 379 – 396 | 18 | Binding to the beta subunit By similarity | ||||||
| Compositional bias | 2050 – 2054 | 5 | Poly-His | ||||||
| Compositional bias | 2118 – 2122 | 5 | Poly-Ser | ||||||
Sites | |||||||||
| Site | 314 | 1 | Calcium ion selectivity and permeability By similarity | ||||||
| Site | 663 | 1 | Calcium ion selectivity and permeability By similarity | ||||||
| Site | 1365 | 1 | Calcium ion selectivity and permeability By similarity | ||||||
| Site | 1655 | 1 | Calcium ion selectivity and permeability By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 455 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 745 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 783 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1719 | 1 | Phosphoserine; by PKA Potential | ||||||
| Modified residue | 1968 | 1 | Phosphoserine Ref.5 | ||||||
| Modified residue | 2256 | 1 | Phosphoserine By similarity | ||||||
| Glycosylation | 256 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 1563 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 1675 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 2164 – 2339 | 176 | GSGSV…QDHWC → AGSAVGFPNTTPCCRETPSA SPWPLALELALTLTWGSVWT VRPLSTPCLRTRSLSRRLWP PTRAAPPGLPTCPP in isoform Alpha-1B-2. | VSP_000882 | |||||
| Natural variant | 167 | 1 | N → K: dbSNP rs4422842. | VAR_048741 | |||||
| Natural variant | 862 | 1 | A → S: dbSNP rs7873074. | VAR_061100 | |||||
| Natural variant | 996 | 1 | T → A: dbSNP rs11137342. | VAR_061101 | |||||
| Natural variant | 1436 | 1 | E → K: dbSNP rs12377346. | VAR_048742 | |||||
| Natural variant | 1500 | 1 | E → K: dbSNP rs12377346. | VAR_048743 | |||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Structure and functional expression of an omega-conotoxin-sensitive human N-type calcium channel." Williams M.E., Brust P.F., Feldman D.H., Patthi S., Simerson S., Maroufi A., McCue A.F., Velicelebi G., Ellis S.B., Harpold M.M. Science 257:389-395(1992) [PubMed: 1321501] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA-1B-1 AND ALPHA-1B-2). Tissue: Brain. |
| [2] | "DNA sequence and analysis of human chromosome 9." Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. Dunham I.Nature 429:369-374(2004) [PubMed: 15164053] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "Isolation and characterization of the 5'-upstream region of the human N-type calcium channel alpha1B subunit gene. Chromosomal localization and promoter analysis." Kim D.S., Jung H.-H., Park S.-H., Chin H. J. Biol. Chem. 272:5098-5104(1997) [PubMed: 9030575] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-94. Tissue: Lung fibroblast. |
| [4] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-455, MASS SPECTROMETRY. Tissue: Epithelium. |
| [5] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1968, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | M94172 mRNA. Translation: AAA51897.1. M94173 mRNA. Translation: AAA51898.1. AL591424, AL772363 Genomic DNA. Translation: CAI40687.1. AL772363, AL591424 Genomic DNA. Translation: CAI17144.1. U76666 Genomic DNA. Translation: AAC51138.1. |
| IPI | IPI00025477. IPI00220431. |
| PIR | A42566. T45115. |
| RefSeq | NP_000709.1. |
| UniGene | Hs.495522 |
3D structure databases | |
| SMR | Q00975. Positions 1147-1227, 1465-1541. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q00975. 1 interaction. |
| STRING | Q00975. |
PTM databases | |
| PhosphoSite | Q00975. |
Proteomic databases | |
| PRIDE | Q00975. |
Genome annotation databases | |
| Ensembl | ENST00000371372; ENSP00000360423; ENSG00000148408; Homo sapiens. [Genome view] |
| GeneID | 774. |
| KEGG | hsa:774. |
| UCSC | uc004cog.1. human. |
Organism-specific databases | |
| CTD | 774. |
| GeneCards | GC09P139892. |
| H-InvDB | HIX0034816. |
| HGNC | HGNC:1389. CACNA1B. |
| MIM | 601012. gene. |
| PharmGKB | PA26008. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG07061. |
| HOVERGEN | Q00975. |
| OrthoDB | EOG9DBWZW. |
Enzyme and pathway databases | |
| Reactome | REACT_13685. Synaptic Transmission. |
Gene expression databases | |
| ArrayExpress | Q00975. |
| Bgee | Q00975. |
| CleanEx | HS_CACNA1B. |
| Genevestigator | Q00975. |
| GermOnline | ENSG00000148408. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR018249. EF_HAND_2. IPR005821. Ion_trans. IPR014873. VDCC_a1su_IQ. IPR005447. VDCC_N_a1su. IPR002077. VDCCAlpha1. [Graphical view] |
| PANTHER | PTHR10037:SF58. NVDCCAlpha1. 1 hit. |
| Pfam | PF08763. Ca_chan_IQ. 1 hit. PF00520. Ion_trans. 4 hits. [Graphical view] |
| PRINTS | PR00167. CACHANNEL. PR01631. NVDCCALPHA1. |
| PROSITE | PS50222. EF_HAND_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| DrugBank | DB00381. Amlodipine. DB00996. Gabapentin. |
| NextBio | 3128. |
| SOURCE | Search... |
Entry information
| Entry name | CAC1B_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q00975 Secondary accession number(s): B1AQK5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


